Proteomics in Multi-omics Workflows Using Yeast as a Model System
Applications | 2013 | Agilent TechnologiesInstrumentation
Mapping proteomics data onto biological pathways accelerates target identification and enhances interpretation of complex datasets in systems biology. Integrating proteomics with other omics layers supports a holistic view of metabolic and regulatory networks, guiding focused experiments and validating discovery findings.
The study demonstrates two complementary workflows using Saccharomyces cerevisiae as a model:
By mapping discovery results to curated yeast pathways and then directing a targeted assay based on metabolite perturbations, the approach illustrates an integrated multi-omics analysis.
Yeast strain BJ5459 was cultured and exposed to cyclosporin A, FK506, calcium stress or vehicle control. Cells were harvested, quenched, lyophilized, bead-beaten with glycerol buffer, and digested via the FASP protocol. Discovery runs used an Agilent 6550 iFunnel Q-TOF with a microfluidic HPLC-Chip over 120-minute gradients in data-dependent acquisition mode. Targeted assays employed an Agilent 6490 Triple Quadrupole in dynamic MRM mode with 90-minute gradients. Data processing combined Agilent Spectrum Mill for peptide–protein identification, Skyline for MRM optimization, and Mass Profiler Professional with Pathways Architect for statistical evaluation and pathway mapping.
The discovery workflow identified 3 446 proteins (1.2 % spectral FDR) and 13 616 unique peptides. PCA showed clear separation of treatment groups. Pathway mapping highlighted down-regulation of ergosterol biosynthesis under FK506 stress. The targeted workflow achieved full coverage of 15 proteins from three salvage and nucleotide biosynthesis pathways, compared to only three proteins detected in the untargeted approach. Dynamic MRM provided sensitive quantitation, and multi-omic visualization in MPP displayed coordinated changes in metabolites and proteins on the adenine/hypoxanthine salvage pathway.
Advances in software for automated pathway-based assay design and deeper integration of genomics, proteomics, and metabolomics will enhance precision medicine, biomarker discovery, and metabolic engineering. Emerging ion mobility and high-field MS technologies promise further gains in sensitivity and throughput.
Combining pathway mapping with discovery and targeted proteomics in a multi-omics framework streamlines hypothesis generation and validation. The demonstrated workflows in yeast underscore the power of integrating metabolite and protein data for focused, high-coverage analysis of critical biological processes.
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesProteomics
ManufacturerAgilent Technologies
Summary
Importance of the Topic
Mapping proteomics data onto biological pathways accelerates target identification and enhances interpretation of complex datasets in systems biology. Integrating proteomics with other omics layers supports a holistic view of metabolic and regulatory networks, guiding focused experiments and validating discovery findings.
Goals and Overview of the Study
The study demonstrates two complementary workflows using Saccharomyces cerevisiae as a model:
- A discovery-driven proteomics pipeline to identify differential proteins under chemical and ionic stress
- A metabolomics-guided targeted proteomics strategy to quantify proteins in specific pathways
By mapping discovery results to curated yeast pathways and then directing a targeted assay based on metabolite perturbations, the approach illustrates an integrated multi-omics analysis.
Methodology and Used Instrumentation
Yeast strain BJ5459 was cultured and exposed to cyclosporin A, FK506, calcium stress or vehicle control. Cells were harvested, quenched, lyophilized, bead-beaten with glycerol buffer, and digested via the FASP protocol. Discovery runs used an Agilent 6550 iFunnel Q-TOF with a microfluidic HPLC-Chip over 120-minute gradients in data-dependent acquisition mode. Targeted assays employed an Agilent 6490 Triple Quadrupole in dynamic MRM mode with 90-minute gradients. Data processing combined Agilent Spectrum Mill for peptide–protein identification, Skyline for MRM optimization, and Mass Profiler Professional with Pathways Architect for statistical evaluation and pathway mapping.
Used Instrumentation
- Agilent 1200 Series HPLC-Chip (360 nL enrichment, 150 mm×75 µm C18)
- Agilent 6550 iFunnel Q-TOF MS (extended dynamic range)
- Agilent 6490 Triple Quadrupole MS (dynamic MRM)
- Spectrum Mill, Skyline, Mass Profiler Professional, Pathways Architect software
Main Results and Discussion
The discovery workflow identified 3 446 proteins (1.2 % spectral FDR) and 13 616 unique peptides. PCA showed clear separation of treatment groups. Pathway mapping highlighted down-regulation of ergosterol biosynthesis under FK506 stress. The targeted workflow achieved full coverage of 15 proteins from three salvage and nucleotide biosynthesis pathways, compared to only three proteins detected in the untargeted approach. Dynamic MRM provided sensitive quantitation, and multi-omic visualization in MPP displayed coordinated changes in metabolites and proteins on the adenine/hypoxanthine salvage pathway.
Benefits and Practical Applications
- Pathway mapping focuses discovery on biologically relevant targets
- Metabolomics-directed assays increase coverage and throughput
- Dynamic MRM enables rapid and sensitive quantitation of pathway proteins
- Multi-omic integration supports comprehensive systems biology investigations
Future Trends and Potential Applications
Advances in software for automated pathway-based assay design and deeper integration of genomics, proteomics, and metabolomics will enhance precision medicine, biomarker discovery, and metabolic engineering. Emerging ion mobility and high-field MS technologies promise further gains in sensitivity and throughput.
Conclusion
Combining pathway mapping with discovery and targeted proteomics in a multi-omics framework streamlines hypothesis generation and validation. The demonstrated workflows in yeast underscore the power of integrating metabolite and protein data for focused, high-coverage analysis of critical biological processes.
Reference
- Jenkins et al., Mass Profiler Professional and Personal Compound Database and Library software facilitate compound identification for profiling of the yeast metabolome: Agilent Technologies 5990-9858EN, 2013.
- Krokhin OV, Sequence-Specific Retention Calculator: Analytical Chemistry, 78, 7785-7795, 2006.
- MacLean B et al., Skyline: an open source editor for targeted proteomics: Bioinformatics, 26, 966-968, 2010.
- Picotti P et al., A complete MS map of the yeast proteome applied to quantitative trait analysis: Nature, 494, 266-270, 2013.
- Wisniewski JR et al., Universal sample preparation method for proteome analysis: Nat Methods, 6, 359-362, 2009.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Accelerate Your Research with Advanced Omics Solutions
2018|Agilent Technologies|OthersPresentations
Accelerate Your Research with Advanced Omics Solutions Christine Miller Omics Market Manager ASMS 2018 ASMS 2018 For Research Use Only. Not for use in diagnostic procedures. Biology Is Integrated Multi-omics increases biological understanding DNA RNA Protein Metabolite • Master program…
Key words
pathway, pathwayatp, atpproteomics, proteomicsagilent, agilentomics, omicsarchitect, architectskyline, skylinepcdl, pcdlmpp, mppanalysis, analysispathways, pathwaysprofiler, profilermetabolomics, metabolomicsflux, fluxtof
Pathways to InsIght
2015|Agilent Technologies|Brochures and specifications
Pathways to Insight Integrated Biology at Agilent “Biological research is expanding enormously in its ability diverse and complementary data types and to inject prior TREY IDEKER, PhD, Departments of Medicine and to decipher complex systems. This ability derives from the…
Key words
genespring, genespringomics, omicsbiology, biologypathway, pathwayintegrated, integratedpathways, pathwaysresearchers, researchersapproaches, approachesagilent, agilentdata, datatranscriptomics, transcriptomicsdiscovery, discoveryngs, ngsarchitect, architectproteomics
A Discovery Proteomics Workflow for the Elucidation of Prostate Cancer Biomarkers
2017|Agilent Technologies|Applications
A Discovery Proteomics Workflow for the Elucidation of Prostate Cancer Biomarkers Application Note Authors Introduction Claire Tonry and Stephen Pennington In biological systems, the host microenvironment is profoundly altered during tumor growth, and this includes becoming hypoxic due to insufficient…
Key words
hof, hofandrogen, androgenlncap, lncapabl, ablhypoxic, hypoxicdifferential, differentialcell, cellproteins, proteinsprotein, proteincancer, cancerpathway, pathwaywere, wereprostate, prostatearchitect, architectdiscovery
Agilent Spectrum Mill Proteomics Software - ACHIEVE SUPERIOR PROTEOMICS RESULTS
2015|Agilent Technologies|Brochures and specifications
Agilent Spectrum Mill Proteomics Software ACHIEVE SUPERIOR PROTEOMICS RESULTS MSTag1 R E b2 2.49e+3 100% F y6++ LT a2 DDE- NR 0 100 T-15ug.12806.12808.2.pkl FR b 2 T L A y5 IL 0 D y1 TD 200 b3 b3 ALT…
Key words
mill, millspectrum, spectrumproteomics, proteomicsdfe, dfeprotein, proteinpathway, pathwaypeptide, peptideproteins, proteinsexport, exportresults, resultssoftware, softwaresearch, searchprofiler, profilermodification, modificationdata